Voya Investment Management LLC Increases Position in Sabra Healthcare REIT, Inc. $SBRA

by · The Cerbat Gem

Voya Investment Management LLC increased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) by 29.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 666,364 shares of the real estate investment trust’s stock after acquiring an additional 152,870 shares during the period. Voya Investment Management LLC owned approximately 0.28% of Sabra Healthcare REIT worth $12,421,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of SBRA. SVB Wealth LLC acquired a new stake in shares of Sabra Healthcare REIT during the first quarter worth about $34,000. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT during the 1st quarter valued at approximately $38,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Sabra Healthcare REIT by 61.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after acquiring an additional 1,065 shares during the period. Finally, Anchor Investment Management LLC purchased a new position in shares of Sabra Healthcare REIT during the first quarter worth $58,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a report on Tuesday, September 2nd. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Wells Fargo & Company raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. National Bankshares set a $22.00 price target on Sabra Healthcare REIT in a research report on Friday, October 17th. Finally, Jefferies Financial Group restated a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and an average price target of $21.00.

Get Our Latest Research Report on SBRA

Sabra Healthcare REIT Trading Down 0.9%

Shares of NASDAQ:SBRA opened at $18.53 on Tuesday. The business’s 50 day moving average price is $18.62 and its 200-day moving average price is $18.56. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $19.97. The firm has a market capitalization of $4.62 billion, a price-to-earnings ratio of 25.74, a price-to-earnings-growth ratio of 1.19 and a beta of 0.67. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.37 by $0.01. The company had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were paid a $0.30 dividend. The ex-dividend date of this dividend was Monday, November 17th. This represents a $1.20 dividend on an annualized basis and a yield of 6.5%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 166.67%.

Sabra Healthcare REIT Company Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Featured Stories